Announcement

Apprentice's Feature Episode on Fox Business

Apprentice discusses the Tempo Manufacturing Cloud on Fox Business' "Trending Today." Watch the full clip here.

January 27, 2022

Company News

Ways to Watch

Apprentice.io appeared in the latest episode of Trending Today, airing on Fox Business. Sign up to receive the recording and learn why Apprentice.io developed a cloud-based platform called Tempo to accelerate the production of new medicines and therapies.

Check out the 60 second episode preview.

Episode Summary

"The Tempo Manufacturing Cloud is a modern and intuitive solution for life sciences that works seamlessly across all stages of drug production to turn a discovered molecule into delivered medicine. The platform is critical for manufacturers to transition their operations to produce next-gen therapies like biologics and personalized medicine - a specific batch of drugs made just for you," says Angelo Stracquatanio III, CEO of Apprentice.io. He co-founded the company, based in Jersey City, New Jersey, with Gary Pignata and Alexandra Buttke in 2014.

Apprentice.io says 15 of the top 20 US pharmaceutical companies use its technology to accelerate the high-quality production of drugs. "Our intelligent software platform helps pharma companies eliminate paper-based processes and more effectively manage production of therapies for all types of diseases, from COVID to cancer. It also helps ensure drug makers are better planning resources, following the highest quality standards, and using real-time data from the system to continuously monitor and improve," Stracquatanio explains.

Throughout the pandemic, Apprentice.io helped produce approximately 370 million doses of the COVID-19 vaccine. "We are helping modernize life sciences to get us out of this pandemic and help the next wave of therapies get to market," Stracquatanio says.

The episode also features Apprentice customers Synthego, a genome engineering company accelerating life science research and development in the pursuit of improved human health, and Catalent, the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world, and Apprentice investor, Silverton Partners, a venture capital fund focused on funding and mentoring early-stage businesses.